OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9811	Companies
196812	Keywords
127831	Articles
104640	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 07/22/2025 at 08:30, 6 months 14 days ago

Oxurion envisage de lancer une stratégie de diversification de sa trésorerie en actifs numériques dans le cadre d'un accord indicatif de 10 M EUR avec son principal investisseur
Oxurion annonce un accord avec Atlas Special Opportunities pour une nouvelle ligne de financement en obligations convertibles de 10M€ allouée à l'investissement en Bitcoin et Ethereum, visant la création de valeur à long terme

Obligations Convertibles Bitcoin Ethereum Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/22/2025 at 08:30, 6 months 14 days ago

Oxurion overweegt een strategie voor diversificatie van zijn kasmiddelen in digitale activa in het kader van een indicatieve overeenkomst van EUR 10 miljoen met zijn belangrijkste investeerder
Oxurion schließt eine 10-Millionen-Euro-Finanzierungslinie in konvertierbaren Anleihen mit Atlas Special Opportunities zur Investition in Bitcoin und Ethereum ab, um seine langfristige Wertschöpfungsstrategie zu unterstützen

Bitcoin Ethereum Oxurion Finanzierungslinie Konvertierbare Anleihen
PRESS RELEASE

published on 07/17/2025 at 09:10, 6 months 19 days ago

Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025
Oxurion NV sichert Finanzierung zur Übernahme von 72% von Axiodis CRO mit dem Ziel, ein integriertes klinisches Datenplattform aufzubauen und strategischer Partner im klinischen Forschungsbereich zu werden

Übernahme Finanzierung Oxurion NV Partnerschaft Klinische Datenplattform
BRIEF

published on 07/17/2025 at 09:05, 6 months 19 days ago

Oxurion finalise l'acquisition partielle d'Axiodis CRO

Acquisition Financement Donnée Clinique Oxurion Axiodis CRO
BRIEF

published on 07/17/2025 at 09:05, 6 months 19 days ago

Oxurion completes partial acquisition of Axiodis CRO

Acquisition Funding Clinical Data Oxurion Axiodis CRO
PRESS RELEASE

published on 07/17/2025 at 09:05, 6 months 19 days ago

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
Oxurion NV secures financing for acquisition of Axiodis CRO, advancing strategic roadmap in clinical data. Targets identified for leading European hub

Acquisition Financing Clinical Data Oxurion NV Axiodis CRO
PRESS RELEASE

published on 07/17/2025 at 09:00, 6 months 19 days ago

Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1eraoût 2025
Oxurion sécurise le financement et acquiert 72% d'Axiodis CRO, renforçant sa position dans la recherche clinique. Projet d'expansion en Europe. Informations sur www.oxurion.com

Acquisition Financement Europe Recherche Clinique Oxurion
BRIEF

published on 07/17/2025 at 08:35, 6 months 19 days ago

Oxurion Sécurise le Financement pour l'Acquisition d'Axiodis CRO

Acquisition Biopharmaceutique Données Cliniques Oxurion Axiodis CRO
BRIEF

published on 07/17/2025 at 08:35, 6 months 19 days ago

Oxurion Secures Financing for Major Acquisition

Acquisition Biopharmaceutical Clinical Data Oxurion Europe Hub
BRIEF

published on 07/17/2025 at 08:35, 6 months 19 days ago

Oxurion obtient un financement pour une acquisition majeure

Acquisition Biopharmaceutique Données Cliniques Oxurion Plateforme Européenne

Accesswire

Published on 02/05/2026 at 15:10, 17 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 37 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 57 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 57 minutes ago

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 14:00, 1 hour 27 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 15:15, 11 minutes ago

FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 15:13, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/05/2026 at 15:12, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 02/05/2026 at 15:12, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/05/2026 at 15:11, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 02/05/2026 at 11:30, 3 hours 57 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 3 hours 57 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours 23 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 21 hours 23 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 21 hours 42 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE